Search Results - "Bournaud, Claire"

Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer by Schlumberger, Martin, Catargi, Bogdan, Borget, Isabelle, Deandreis, Désirée, Zerdoud, Slimane, Bridji, Boumédiène, Bardet, Stéphane, Leenhardt, Laurence, Bastie, Delphine, Schvartz, Claire, Vera, Pierre, Morel, Olivier, Benisvy, Danielle, Bournaud, Claire, Bonichon, Françoise, Dejax, Catherine, Toubert, Marie-Elisabeth, Leboulleux, Sophie, Ricard, Marcel, Benhamou, Ellen

“…This trial compared two thyrotropin-stimulation methods and two 131I doses for postoperative ablation in patients with low-risk thyroid cancer. Rates of…”
Get full text

RADTHYR: an open-label, single-arm, prospective multicenter phase II trial of Radium-223 for the treatment of bone metastases from radioactive iodine refractory differentiated thyroid cancer by Deandreis, Désirée, Maillard, Aline, Zerdoud, Slimane, Bournaud, Claire, Vija, Lavinia, Sajous, Christophe, Terroir, Marie, Leenhardt, Laurence, Schlumberger, Martin, Borget, Isabelle, Leboulleux, Sophie

“…Purpose This is the first prospective trial evaluating the efficacy of alpha emitter Radium-223 in patients with bone metastases from radioactive iodine (RAI)…”
Get full text

Predictive value of maternal second-generation thyroid-binding inhibitory immunoglobulin assay for neonatal autoimmune hyperthyroidism by Abeillon-du Payrat, Juliette, Chikh, Karim, Bossard, Nadine, Bretones, Patricia, Gaucherand, Pascal, Claris, Olivier, Charrié, Anne, Raverot, Véronique, Orgiazzi, Jacques, Borson-Chazot, Françoise, Bournaud, Claire

“…ContextHyperthyroidism occurs in 1% of neonates born to mothers with active or past Graves' disease (GD). Current guidelines for the management of GD during…”
Get full text

Results of combined treatment of anaplastic thyroid carcinoma (ATC) by Derbel, Olfa, Limem, Sami, Ségura-Ferlay, Céline, Lifante, Jean-Christophe, Carrie, Christian, Peix, Jean-Louis, Borson-Chazot, Françoise, Bournaud, Claire, Droz, Jean-Pierre, de la Fouchardière, Christelle

“…Anaplastic thyroid carcinoma (ATC) is among the most aggressive human malignancies. It is associated with a high rate of local recurrence and with poor…”
Get full text

Pregnant French women living in the Lyon area are iodine deficient and have elevated serum thyroglobulin concentrations by Raverot, Véronique, Bournaud, Claire, Sassolas, Geneviève, Orgiazzi, Jacques, Claustrat, Francine, Gaucherand, Pascal, Mellier, Georges, Claustrat, Bruno, Borson-Chazot, Françoise, Zimmermann, Michael

“…Iodine deficiency (ID) remains common in Europe, and may be especially detrimental during pregnancy. The aim of our study was to assess iodine status and…”
Get more information

Tissue dose estimation after extravasation of 177Lu-DOTATATE by Tylski, Perrine, Pina-Jomir, Géraldine, Bournaud-Salinas, Claire, Jalade, Patrice

“…Background Extravasation of radiopharmaceuticals used for vectorized internal radiotherapy can lead to severe tissue damage (van der Pol et al., Eur J Nucl Med…”
Get full text

Predictive factors of outcome in poorly differentiated thyroid carcinomas by de la Fouchardière, Christelle, Decaussin-Petrucci, Myriam, Berthiller, Julien, Descotes, Françoise, Lopez, Jonathan, Lifante, Jean-Christophe, Peix, Jean-Louis, Giraudet, Anne-Laure, Delahaye, Armelle, Masson, Sandrine, Bournaud-Salinas, Claire, Borson Chazot, Françoise

“…The prognosis of poorly differentiated thyroid carcinomas (PDTC) is heterogeneous though generally poor. The objectives of this study were to identify clinical…”
Get full text

Evaluation of Gene Expression Profiles in Thyroid Nodule Biopsy Material to Diagnose Thyroid Cancer by Durand, Stéphanie, Ferraro-Peyret, Carole, Selmi-Ruby, Samia, Paulin, Christian, El Atifi, Michelle, Berger, François, Berger-Dutrieux, Nicole, Decaussin, Myriam, Peix, Jean-Louis, Bournaud, Claire, Orgiazzi, Jacques, Borson-Chazot, Françoise, Rousset, Bernard

“…Context: Detection of thyroid cancer among benign nodules on fine-needle aspiration biopsies (FNAB), which presently relies on cytological examination, is…”
Get full text

Geographical correlation between incidence of benign disease and that of cancer of the thyroid among the population of the Rhône-Alpes région of France by Sassolas, Geneviève, Hafdi-Nejjari, Zakia, Schott, Anne Marie, Bournaud, Claire, Peix, Jean Louis, Orgiazzi, Jacques, Dutrieux-Berger, Nicole, Borson-Chazot, Françoise

“…ObjectiveTo analyze, at a population level, the relation between the incidences of benign thyroid diseases in patients submitted to surgery and that of thyroid…”
Get full text

Evidence for Transcriptional and Posttranscriptional Alterations of the Sodium/Iodide Symporter Expression in Hypofunctioning Benign and Malignant Thyroid Tumors by Trouttet-Masson, Séverine, Selmi-Ruby, Samia, Bernier-Valentin, Françoise, Porra, Valérie, Berger-Dutrieux, Nicole, Decaussin, Myriam, Peix, Jean-Louis, Perrin, Agnès, Bournaud, Claire, Orgiazzi, Jacques, Borson-Chazot, Françoise, Franc, Brigitte, Rousset, Bernard

“…The uptake of iodide by epithelial thyroid cells requires the expression of a specific transporter, the Na +/I − symporter, NIS. Benign and malignant thyroid…”
Get full text

131I Effective Half-Life and Dosimetry in Thyroid Cancer Patients by Remy, Herve, Borget, Isabelle, Leboulleux, Sophie, Guilabert, Nadine, Lavielle, Frederic, Garsi, Jerome, Bournaud, Claire, Gupta, Severine, Schlumberger, Martin, Ricard, Marcel

“…(131)I treatment in thyroid cancer patients may induce side effects, including extrathyroidal cancer and leukemia. There are still some uncertainties…”
Get full text

Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy by Laurberg, Peter, Bournaud, Claire, Karmisholt, Jesper, Orgiazzi, Jacques

“…Graves' disease is a common autoimmune disorder in women in fertile ages. The hyperthyroidism is causedby generation of TSH-receptor activating antibodies. In…”
Get full text

Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer by Leboulleux, Sophie, Bournaud, Claire, Chougnet, Cecile N., Zerdoud, Slimane, Al Ghuzlan, Abir, Catargi, Bogdan, Do Cao, Christine, Kelly, Antony, Barge, Marie-Luce, Lacroix, Ludovic, Dygai, Inna, Vera, Pierre, Rusu, Daniela, Schneegans, Olivier, Benisvy, Danielle, Klein, Marc, Roux, Julie, Eberle, Marie-Claude, Bastie, Delphine, Nascimento, Camila, Giraudet, Anne-Laure, Le Moullec, Nathalie, Bardet, Stéphane, Drui, Delphine, Roudaut, Nathalie, Godbert, Yann, Morel, Olivier, Drutel, Anne, Lamartina, Livia, Schvartz, Claire, Velayoudom, Fritz-Line, Schlumberger, Martin-Jean, Leenhardt, Laurence, Borget, Isabelle

“…In this randomized phase 3 trial involving patients with low-risk differentiated thyroid cancer undergoing thyroidectomy, a follow-up strategy that did not…”
Get full text

A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer by Leboulleux, Sophie, Do Cao, Christine, Zerdoud, Slimane, Attard, Marie, Bournaud, Claire, Lacroix, Ludovic, Benisvy, Danielle, Taïeb, David, Bardet, Stéphane, Terroir-Cassou-Mounat, Marie, Anizan, Nadège, Bouvier-Morel, Emilie, Lamartina, Livia, Lion, Georges, Betrian, Sarah, Sajous, Christophe, Schiazza, Aurélie, Garcia, Marie-Eve, Ciappuccini, Renaud, Schlumberger, Martin, Al Ghuzlan, Abir, Godbert, Yann, Borget, Isabelle

“…To evaluate the efficacy and safety of dabrafenib-trametinib-131I for the treatment of radioactive iodine refractory metastatic differentiated thyroid cancer…”
Get full text

Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial by Schlumberger, Martin, Leboulleux, Sophie, Catargi, Bogdan, Deandreis, Desiree, Zerdoud, Slimane, Bardet, Stephane, Rusu, Daniela, Godbert, Yann, Buffet, Camille, Schvartz, Claire, Vera, Pierre, Morel, Olivier, Benisvy, Danielle, Bournaud, Claire, Toubert, Marie-Elisabeth, Kelly, Antony, Benhamou, Ellen, Borget, Isabelle

“…In ESTIMABL1, a randomised phase 3 trial of radioactive iodine (131I) administration after complete surgical resection in patients with low-risk thyroid…”
Get full text

Amino Acid Solutions for [sup.177]Lu-Oxodotreotide Premedication: A Tolerance Study by Courault, Pierre, Deville, Agathe, Habouzit, Vincent, Gervais, Frédéric, Bolot, Claire, Bournaud, Claire, Levigoureux, Elise

“…[[sup.177] Lu]oxodotreotide (Lutathera[sup.®] ) was approved by the European Medical Agency in 2017 and the Food and Drug Administration in 2018 for the…”
Get full text

TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma by Bournaud, Claire, Descotes, Françoise, Decaussin-Petrucci, Myriam, Berthiller, Julien, de la Fouchardière, Christelle, Giraudet, Anne-Laure, Bertholon-Gregoire, Mireille, Robinson, Philip, Lifante, Jean-Christophe, Lopez, Jonathan, Borson-Chazot, Françoise

“…TERT promoter mutations are associated with adverse clinicopathological characteristics in thyroid carcinomas and considered as a major indicator of poor…”
Get full text

Amino Acid Solutions for 177 Lu-Oxodotreotide Premedication: A Tolerance Study by Courault, Pierre, Deville, Agathe, Habouzit, Vincent, Gervais, Frédéric, Bolot, Claire, Bournaud, Claire, Levigoureux, Elise

“…Background: The co-infusion of amino acid solutions during peptide receptor radionuclide therapy reduces the tubular reabsorption of 177Lu-oxodotreotide, thus…”
Get full text

Amino Acid Solutions for 177Lu-Oxodotreotide Premedication: A Tolerance Study by Courault, Pierre, Deville, Agathe, Habouzit, Vincent, Gervais, Frédéric, Bolot, Claire, Bournaud, Claire, Levigoureux, Elise

“…Background: The co-infusion of amino acid solutions during peptide receptor radionuclide therapy reduces the tubular reabsorption of 177Lu-oxodotreotide, thus…”
Get full text

Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial by Borget, Isabelle, Bonastre, Julia, Catargi, Bogdan, Déandréis, Désirée, Zerdoud, Slimane, Rusu, Daniela, Bardet, Stéphane, Leenhardt, Laurence, Bastie, Delphine, Schvartz, Claire, Vera, Pierre, Morel, Olivier, Benisvy, Daniele, Bournaud, Claire, Bonichon, Francoise, Kelly, Antony, Toubert, Marie-Elisabeth, Leboulleux, Sophie, Journeau, Florence, Benhamou, Ellen, Schlumberger, Martin

“…In the ESTIMABL phase III trial, the thyroid ablation rate was equivalent for the two thyroid-stimulating hormone (TSH) stimulation methods (thyroid hormone…”
Get full text